azacitidine and Adamantiades-Behcet Disease

azacitidine has been researched along with Adamantiades-Behcet Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Akemoto, Y; Chinda, D; Fukuda, S; Hasui, K; Hiraga, H; Ishiguro, Y; Kamata, K; Kikuchi, H; Kishida, D; Maeda, T; Mayama, K; Mikami, T; Murai, Y; Ota, S; Sakuraba, H; Sawaya, M; Tanaka, M; Tanaka, N; Tatsuta, T; Watanabe, R; Yamagata, K1
Ades, L; Fain, O; Fenaux, P; Jachiet, V; Mekinian, A; Wesner, N1
Matsuguma, M; Nakamura, Y; Tanaka, M; Tanaka, Y; Tanizawa, Y; Tokunaga, Y; Yamamoto, K; Yujiri, T1
Hashimoto, S; Kawajiri, C; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Takagi, T; Takeda, Y; Takeuchi, M; Tanaka, H; Tougasaki, E1
Endo, M; Maruo, T; Osaki, Y; Sekikawa, A; Tsumura, T1

Other Studies

5 other study(ies) available for azacitidine and Adamantiades-Behcet Disease

ArticleYear
Long-term maintenance of the mucosal healing induced by azacitidine therapy in a patient with intestinal Behçet's-like disease accompanied with myelodysplastic syndrome involving trisomy 8.
    Immunological medicine, 2019, Volume: 42, Issue:3

    Topics: Azacitidine; Behcet Syndrome; Chromosomes, Human, Pair 8; Female; Humans; Intestinal Diseases; Maintenance Chemotherapy; Middle Aged; Myelodysplastic Syndromes; Time Factors; Treatment Outcome; Trisomy

2019
[Behçet's-like syndrome and other dysimmunitary manifestations related to myelodysplastic syndromes with trisomy 8].
    La Revue de medecine interne, 2021, Volume: 42, Issue:3

    Topics: Azacitidine; Behcet Syndrome; Chromosomes, Human, Pair 8; Humans; Myelodysplastic Syndromes; Trisomy

2021
Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:10

    Topics: Adult; Antimetabolites, Antineoplastic; Asian People; Azacitidine; Behcet Syndrome; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Remission Induction; Tacrolimus; Transplantation, Homologous; Treatment Outcome

2017
Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.
    International journal of hematology, 2013, Volume: 97, Issue:4

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Behcet Syndrome; Bone Marrow; Colonoscopy; Humans; Intestinal Diseases; Intestines; Male; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome

2013
A Case of Myelodysplastic Syndrome with Intestinal Behçet's Disease-Like Symptoms Treated by Prednisolone and Azacitidine.
    The American journal of case reports, 2015, Nov-21, Volume: 16

    Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Behcet Syndrome; Bone Marrow Cells; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Glucocorticoids; Humans; Ileal Diseases; Myelodysplastic Syndromes; Prednisolone

2015